Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors25. August 2025
News ForSight Robotics Raises $125M for Ophthalmic Robotic SurgeryHealthradar24. Juni 2025 What You Should Know: – ForSight Robotics, the pioneer in ophthalmic robotic surgery secures $125M Series B round, led by…
